Genes & Diseases
Article number: 101681
< Back to all reports
Review Status:
{{reviewData.commendedNum}} Commended
, {{reviewData.revisionRequiredNum}} Revision
Required
, {{reviewData.notCommendedNum}} Not Commended
Under
Peer Review
Cite this article:
Mai X, Wang L, Tu J, et al.
A novel oridonin analogue, CYD0682, suppresses breast cancer growth, angiogenesis, and metastasis by inhibiting the ANGPTL4/MAPK signaling axis.
Genes & Diseases,
2025, 12(5): 101681.
https://doi.org/10.1016/j.gendis.2025.101681
Metrics & Citations
Received: 24 July 2024
Published:
08 May 2025
© 2025 The Authors.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Comments on this article